查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1138395

全球生物可吸收植入物市場2022-2029

Global Bioresorbable Implants Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場動態

競爭對手對獲得 FDA 批准的關注有望推動市場

近年來，許多生物可吸收植入物已成為各種適應症的可行替代品。這些可生物吸收的植入物在人體中溶解並取代天然骨骼。稍大的植入物需要與植入物集成的互連多孔組件，以實現更好的血管供應。增材製造技術允許直接製造這種相互連接的多孔結構。市場上的主要競爭對手專注於獲得 FDA 批准用於治療患者的新產品。例如，波士頓科學公司推出了由金屬鉑和鉻組成的 SYNERGY 生物可吸收聚合物藥物洗脫支架系統。該支架因其最佳的癒合特性和復雜病例的治療選擇而受到全球醫生的高度評價。此外，根據 2021 年 5 月 23 日的新聞稿， Bioretec Ltd. 的 RemeOs 螺釘已獲得 FDA 突破性設備指定，用於創傷學和骨科。新產品用於矯正骨折、畸形和錯位。這些螺釘由生物活性合金製成，含有人體的天然元素，如鎂、鋅和鈣，有助於促進新骨的形成。 2020年3月23日，Durysta（比馬前列素植入物）獲得美國食品藥品監督管理局（Food and Drug Administration）（ FDA ）的批准，用於治療開角型青光眼或高眼壓症患者。植入物直接注入眼睛並在較長時間內釋放比馬前列素。因此，從上述陳述來看，預計將在預測期內推動市場。

約束

高昂的系統維護和安裝成本、擔心失去對外包流程的控制、對數據安全和服務質量的擔憂以及經濟戰略的快速變化是在預測期內阻礙市場發展的一些因素。據信那

行業分析

生物可吸收植入物市場根據各種行業因素（包括未滿足的需求、定價分析、供應鏈分析和監管分析）對市場進行深入分析。

COVID-19 影響分析

COVID-19 大流行對全球生物可吸收植入物市場產生了重大影響。這場大流行給全球醫療保健系統帶來了壓力，醫院推遲了骨科手術等選擇性手術，並限制了對生物可吸收植入物的需求。 COVID-19 正在限制化學和材料行業的運營並阻礙全球市場。供應鏈中斷和原材料採購困難在一定程度上限制了生物可吸收植入物市場。儘管存在這些短期挑戰，但預計生物可吸收植入物的全球市場在未來幾年將經歷顯著增長。

生物可吸收植入物全球市場報告提供大約 45 多個市場數據表、40 多個數字和 180 頁內容。

內容

第一章研究方法與範圍

  • 調查方法
  • 調查範圍

第 2 章定義和概述

第 3 章執行摘要

  • 按材料類型劃分的市場細分
  • 按應用劃分的市場細分
  • 最終用戶的市場細分
  • 按地區劃分的市場細分

第 4 章市場動態

  • 市場影響因素
  • 驅動程序
  • 限制因素
  • 影響分析

第五章產業力量

  • 波特五力分析
  • 供應鏈分析
  • 流行病學
  • 主要趨勢及發展現狀

第 6 章 COVID-19 分析

  • COVID-19 的市場分析

第 7 章按材料類型

  • 金屬
  • 高分子材料
  • PLGA-聚乳酸-乙醇酸
  • PLLA-聚 L-丙交酯
  • PGA-聚乙醇酸
  • PLA聚乳酸
  • 其他

第 8 章按應用程序

  • 心髒病學
  • 骨科
  • 其他

第 9 章，最終用戶

  • 醫院
  • 門診手術中心
  • 其他

第 10 章按地區劃分

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 意大利
    • 其他歐洲地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲

第 11 章競爭格局

  • 競爭場景

第 12 章公司簡介

  • Bioretec Ltd
    • 公司概況
    • 產品組合和描述
    • 主要亮點
    • 財務摘要
  • Stryker Corporation（Wright Medical）
  • ConMed Corporation
  • Syntellix AG
  • Johnson & Johnson Medical Devices（DePuy Synthes）
  • Zimmer Biomet Holdings
  • Becton, Dickinson and Company（C.R. Bard）
  • NuVasive Inc.
  • KLS Martin
  • Smith & Nephew
  • Medtronic Plc

第13章 DataM

簡介目錄
Product Code: DMMD887

Market Overview

Bioresorbable Implants Market size was valued US$ YY million in 2021 and is estimated to reach US$ YY million by 2029, growing at a CAGR of 7.40% during the forecast period (2022-2029).

Bioabsorbable implants are the ones that absorb in the body. Bioresorbable materials used for the implants slowly diffuse in the human body, so a second surgery to remove the Synthetic material is not required. The materials used in bioabsorbable implants can be synthetic and natural. Bioabsorbable implants have a wide range of indications, from ocular implants to fixations of bone grafts.

Market Dynamics

Leading Competitors in the market are concentrating their efforts on obtaining FDA clearance is expected to drive the market.

Recently, many bioresorbable implants have been made available as a feasible alternative to various indications. These bioresorbable implants dissolve in the human body and then get replaced by natural bones. For the somewhat large implants, interconnecting porous assembly is needed so that it can be integrated with the implant for better vascularization. The additive manufacturing technology, this interconnecting porous structure can be manufactured directly. The leading competitors in the market are concentrating their efforts on obtaining FDA clearance for novel products to treat patients. For instance, Boston Scientific launched its SYNERGY Bioabsorbable Polymer Drug-Eluting Stent System consisting of platinum and chromium metals. This stent is highly accepted amongst physicians worldwide because of its optimal healing property and treatment options for complex cases. Also, on May 23, 2021, Bioretec Ltd. received FDA breakthrough device designation of its RemeOs Screws for use in traumatology and orthopedic surgery, according to a press release. The new products are intended for bone fractures and for correcting deformities or malalignments. Created from a bioactive alloy, the screws contain elements natural to the body, like magnesium, zinc and calcium, which help promote new bone formation. On March 23, 2020, Durysta (bimatoprost implant) received approval from the US Food and Drug Administration (FDA) for treating patients with open-angle glaucoma or ocular hypertension. The implant is administered directly into the eye, where it releases bimatoprost for an extended period. Thus, from the above statements, the market is expected to drive in the forecast period.

Restraint:

The high cost of system maintenance and installation, the fear of losing control over the outsourced process, concerns about data security and service quality, and rapid changes in economic strategies are some factors the market is expected to get hampered in the forecast period.

Industry Analysis

The bioresorbable implants market provides in-depth analysis of the market based on various industry factors such as unmet needs, pricing analysis, supply chain analysis, regulatory analysis etc.

COVID-19 Impact Analysis

The COVID-19 pandemic had a major impact on the global bioabsorbable implants market. The pandemic burdened healthcare systems globally and hospitals postponed elective surgeries such as orthopedic surgeries, restricting the demand for bioresorbable implants. COVID-19 has limited the operations of the chemicals and materials industry, hampering the global market. Supply chain disruptions and difficulty in procuring raw materials have somewhat restrained the bioresorbable implants market. Despite these short-term challenges, the global bioabsorbable implants market is expected to generate significant growth in the coming years.

Segment Analysis

PLGA- Poly lactic-co-glycolic acid segment is expected to be the dominant segment in the market during the forecast period.

The PLGA- Poly lactic-co-glycolic acid segment accounted for the largest market share in 2021. PLGA- Poly lactic-co-glycolic acid is one of the most strongly biodegradable polymers. It is an FDA-approved Generally Recognized as Safe (GRAS) polymer used in various resorbable surgical devices such as meshes, sutures and ligatures. PLGA is a copolymer for drug delivery owing to its mechanical properties, biodegradability, biocompatibility, and ease of processing. It has been used to provide various vascular tissue-engineering devices, such as grafts and prosthetic devices. Early generations of PGA resorbable implants have been known to cause local effects during bio-absorption, and the rapid degeneration of the implants may cause uncertainty before healing occurs. Specifically, PLGA materials are also developed for the dental field in films, membranes, nanoparticles or microparticles. PLGA membranes have been studied with promising results, alone or combined with other elements in bone healing procedures. Biocompatibility, flexibility, biodegradability and minimal side effects are the main benefits when using this polymer for biomedical applications. In particular, PLGA has mainly been studied to develop devices for the controlled delivery of small molecule drugs, proteins and other macromolecules in commercial use and research. Thus, from the above statements, the market segment accounted for the largest market share in the forecast period.

Geographical Analysis

North American region is expected to hold the largest market share in the global bioresorbable implants market.

The North American bioabsorbable implants market is expected to hold the largest regional share of the global market, owing to factors such as a high prevalence of cardiovascular disease and an increase in the geriatric population, which is expected to increase the number of cases of osteoporosis and osteoarthritis. Technological advancement in bioabsorbable implants, increasing medical innovation and approval of new implants by the FDA are also factors driving the growth of the North American market. For instance, Stryker has developed a new bioabsorbable implant, SonicAnchor, used for suture and tissue fixation. The implant employs ultrasonic energy to liquefy and flow into the cancellous bone for secure fixing. The device is suitable for suture or tissue fixation in ankle, foot, knee, wrist, hand, elbow, and shoulder open operations. Manufacturers are combining strategies to improve patient care. Moreover, in June 2022, a team of researchers from Northwestern University developed a new type of flexible bioabsorbable implant that relieves pain in patients without using drugs.

Competitive Landscape

Major key players in the bioresorbable implants market are Bioretec Ltd, Stryker Corporation, ConMed Corporation, Syntellix AG, Johnson & Johnson, Zimmer Biomet, Becton Dickinson and Company, KLS Martin, Smith and Nephew and Evonik Industries AG, among others.

Bioretec Ltd.:

Overview:

Bioretec Ltd. is a medical device company focusing on developing strong, safe and reliable bioabsorbable and bioresorbable implants for pediatric and adult orthopedics. The company's products are used worldwide, and it continues to develop materials and products for load-bearing further clinical applications. The company's work is under ISO 13485:2016 and FDA Part 820. All the Activa products hold CE certificates, and most are also 510(k) cleared by the FDA.

Product Portfolio:

RemeOs Screw bioresorbable magnesium implants: RemeOs bioresorbable metallic implants are in the clinical testing phase. These implants will offer a strong and bioresorbable solution for load-bearing medical operations. These implants eliminate implant removal while still maintaining strength and rigidity close to traditional steel or titanium implants.

The global bioresorbable Implants market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research methodology
  • 1.2. Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Market Snippet by Material Type
  • 3.2. Market Snippet by Application
  • 3.3. Market Snippet by End-User
  • 3.4. Market Snippet by Region

4. Market Dynamics

  • 4.1. Market Impacting Factors
  • 4.2. Drivers
  • 4.3. Restraints
  • 4.4. Impact Analysis

5. Industry Forces

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Epidemiology
  • 5.4. Key Trends and Developments

6. By COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market

7. By Material Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material Type
    • 7.1.2. Market Attractiveness Index, By Material Type
  • 7.2. Metallic*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2019-2027 and Y-o-Y Growth Analysis (%), 2020-2027
  • 7.3. Polymers
    • 7.3.1. Introduction
    • 7.3.2. Market Size Analysis, US$ Million, 2019-2027 and Y-o-Y Growth Analysis (%), 2020-2027
  • 7.4. PLGA- Polylactic-co-glycolic acid
  • 7.5. PLLA- Poly L-lactide
  • 7.6. PGA- Polyglycolic Acid
  • 7.7. PLA- Polylactic Acid
  • 7.8. Others

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Cardiovascular*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2019-2027 and Y-o-Y Growth Analysis (%), 2020-2027
  • 8.3. Orthopedics
  • 8.4. Others

9. By End-User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
    • 9.1.2. Market Attractiveness Index, By End-User
  • 9.2. Hospitals*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2019-2027 and Y-o-Y Growth Analysis (%), 2020-2027
  • 9.3. Ambulatory Surgical Centers
  • 9.4. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material Type
    • 10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
    • 10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. South America
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material Type
    • 10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
    • 10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Brazil
      • 10.3.6.2. Argentina
      • 10.3.6.3. Rest of South America
  • 10.4. Europe
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material Type
    • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
    • 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Germany
      • 10.4.6.2. U.K.
      • 10.4.6.3. France
      • 10.4.6.4. Spain
      • 10.4.6.5. Italy
      • 10.4.6.6. Rest of Europe
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material Type
    • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
    • 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia Pacific
  • 10.6. Middle East & Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material Type
    • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

  • 11.1. Competitive Scenario

12. Company Profiles

  • 12.1. Bioretec Ltd*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. Stryker Corporation (Wright Medical)
  • 12.3. ConMed Corporation
  • 12.4. Syntellix AG
  • 12.5. Johnson & Johnson Medical Devices (DePuy Synthes)
  • 12.6. Zimmer Biomet Holdings
  • 12.7. Becton, Dickinson and Company (C.R. Bard)
  • 12.8. NuVasive Inc.
  • 12.9. KLS Martin
  • 12.10. Smith & Nephew
  • 12.11. Medtronic Plc

13. DataM Intelligence

  • 13.1. Appendix
  • 13.2. About Us and Services
  • 13.3. Contact Us